Misoprostol for postpartum hemorrhage prevention at home birth: An integrative review of global implementation experience to date

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Smith, Jeffrey Michael ^a   Gubin, Rehana ^a   Holston, Martine M ^b   Fullerton, Judith ^c   Prata, Ndola ^d  

^a JHPIEGO   (United States)

^b Venture Strategies Innovations   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Community based distribution mechanisms; Coverage; Home birth; Misoprostol; Postpartum hemorrhage; Safety; Serious adverse events

Indexed keywords

MISOPROSTOL; PLACEBO;

ARTICLE; DRUG SAFETY; DRUG USE; FEMALE; HEALTH CARE UTILIZATION; HOME DELIVERY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE;

COMMUNITY HEALTH WORKERS; DEVELOPING COUNTRIES; FEMALE; HOME CHILDBIRTH; HUMANS; MATERNAL MORTALITY; MIDWIFERY; MISOPROSTOL; OXYTOCICS; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; SELF ADMINISTRATION; WORLD HEALTH ORGANIZATION;

EID: 84873942958     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-44     Document Type: Article

References (46)

1. WHO, UNICEF, UNFPA World Bank, Trends in maternal mortality: 1990-2010 2012, http://www.unfpa.org/public/home/publications/pid/10728, WHO, UNICEF, UNFPA.
2. Khan K, Wojdyla D, Say L, Gulmezolglu AM, Van Look P. WHO analysis of causes of maternal death: a systematic review. Lancet 2006, 367:1066-1074. 10.1016/S0140-6736(06)68397-9, 16581405.
3. Haeri S, Dildy GA. Maternal mortality from hemorrhage. Semin Perinatol 2012, 36:48-55. 10.1053/j.semperi.2011.09.010, 22280866.
4. Carroli G, Cuesta C, Abalos E, Gulmezoglu A. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008, 22:999-1012. 10.1016/j.bpobgyn.2008.08.004, 18819848.
5. Leduc D, Senikas V, Lalonde AB, Ballerman C, Biringer A, Delaney M, Duperron L, Girard I, Jones D, Lee LS, Shepherd D, Wilson K. Active management of the third stage of labour: prevention and treatment of postpartum hemorrhage. J Obstet Gynaecol Can 2009, 31:980-993.
6. World Health Organization Choice of uterotonic agents in active management of the third stage of labour 2008, http://apps.who.int/rhl/pregnancy_childbirth/childbirth/3rd_stage/cd000201_abalose_com/en/index.html, World Health Organization.
7. Prata N, Passano P, Rowen T, Bell S, Walsh J, Potts M. Where there are (few) skilled attendants. J Health Popul Nutr 2011, 29(2):81-91. 3126980, 21608417.
8. Crowe S, Utley M, Costello A, Pagel C. How many births in sub-Saharan Africa and South Asia will not be attended by a skilled birth attendant between 2011 and 2015?. BMC Pregnancy Childbirth 2012, 12:4. 10.1186/1471-2393-12-4, 3274439, 22251749.
9. Montagu D, Yarney G, Visconti A, Harding A, Yoong J. Where do poor women in developing countries give birth? A multi-country analysis of demographic and health survey data. PLoS One 2011, 6:e17155. 10.1371/journal.pone.0017155, 3046115, 21386886.
10. Diaz-Granados N, Pitzul K, Dorado L, Wang F, McDermott S, Rondon M, By: Diaz-Granados N, Pitzul KB, Dorado LM, Wang F, McDermott S, Rondon MB. Monitoring gender equity in health using gender-sensitive indicators: A cross-national study. J Women's Health 2011, 20:145-153. 10.1089/jwh.2010.2057, 23463670.
11. Payne S. An elusive goal? Gender equity and gender equality in health policy. Gesundheitswen 2012, 74:e19-24.
12. Pagel C, Lewychka S, Colbourn T, Mwansambo C, Meguid T, Chiudzu G, Utley M, Costello AM. Estimation of potential effects of improved community-based drug provision to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model. Lancet 2009, 374(9699):1441-1448. 10.1016/S0140-6736(09)61566-X, 19783291.
13. Prata N, Gessessew A, Abraha AK, Holson M, Potts M. Prevention of postpartum hemorrhage: options for home births in rural Ethiopia. Af J Reproductive Health 2009, 13:87-95.
14. E-Nasreen H, Nahar S, Al Mamun M, Afsana K, Byass P. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it. Global Health Action 2011, 4. Date of E-pub: 2011 Aug 10.
15. Mobeen N, Durocher J, Zuberi N, Jahan N, Blum J, Wasim S, Walraven G, Hatcher J. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomized placebo-controlled trial. BJOG 2011, 118:353-361. 10.1111/j.1471-0528.2010.02807.x, 3041931, 21176086.
16. Alfirevic Z, Blum J, Walraven G, Weeks A, Winikoff B. Prevention of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet 2007, 99(Suppl 2):S198-201.
17. Chaudhuri P, Biswas J, Mandal A. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women. Int J Gynaecol Obstet 2012, 116:138-142. 10.1016/j.ijgo.2011.09.016, 22100204.
18. Sheldon WR, Blum J, Durocher J, Winikoff B. Misoprostol for the prevention and treatment of postpartum hemorrhage. Expert Opin Investig Drugs 2012, 21:235-250. 10.1517/13543784.2012.647405, 22233426.
19. Starrs A, Winikoff B. Misoprostol for postpartum hemorrhage: Moving from evidence to practice. Int J Gynecol Obstet 2012, 116:1-3.
20. World Health Organization Model List of Essential Medicines. 17th list 2011, http://www.who.int/medicines/publications/essentialmedicines/en, World Health Organization.
21. Chu C, Brhlikova P, Pollock A. Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage. J R Soc Med 2012, 105:336-347. 10.1258/jrsm.2012.120044, 22907551.
22. Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, Patted SS, Patel A, Edlavitch SA, Hartwell T, Chakraborty H, Moss N. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomized controlled trial. Lancet 2006, 368:1248-1253. 10.1016/S0140-6736(06)69522-6, 17027730.
23. Rajbhandari S, Hodgins S, Sanghvi H, McPherson R, Pradhan YV, Baqui AH. Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal. Int J Gynaecol Obstet 2010, 108:282-288. 10.1016/j.ijgo.2009.11.006, 20034628.
24. Sanghvi H, Ansari N, Prata NJ, Gibson H, Ehsan AT, Smith JM. Prevention of postpartum hemorrhage at home birth in Afghanistan. Int J Gynaecol Obstet 2010, 108:276-281. 10.1016/j.ijgo.2009.12.003, 20053399.
25. Sutherland T, Meyer C, Bishai DM, Geller S, Miller S. Community-based distribution of misoprostol for treatment or prevention of postpartum hemorrhage; cost effectiveness, mortality, and morbidity reduction analysis. Int J Gynaecol Obstet 2010, 108:289-294. 10.1016/j.ijgo.2009.11.007, 20079493.
26. World Health Organization WHO recommendations for the prevention and treatment of postpartum haemorrhage 2012, http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548502/en/index.html, World Health Organization.
27. Oladapo OT, Fawole B, Blum J, Abalos E. Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database Syst Rev 2012, 2:CD009336. Cochrane AN.
28. Oladapo OT. Misoprostol for preventing and treating postpartum hemorrhage in the community: A closer look at the evidence. Int J Gynaecol Obstet 2012, 119:105-116. 10.1016/j.ijgo.2012.08.004, 22968139.
29. Whittemore R, Knaft K. The integrative review: updated methodology. J Adv Nurs 2005, 52(5):546-553. 10.1111/j.1365-2648.2005.03621.x, 16268861.
30. De Souza MT, Dias Da Silva M, De Carvalho R. Integrative review: what is it? How to do it?. Einstein 2010, 8(Pt 1):102-106.
31. Shorn MN. Measurement of blood loss: review of the literature. J Midwif Womens Health 2010, 5:20-27.
32. Sloan NL, Durocher J, Aldrich T, Blum J, Winikoff B. What measured blood loss tells us about postpartum bleeding: a systematic review. BJOG 2010, 117(7):788-800. 10.1111/j.1471-0528.2010.02567.x, 2878601, 20406227.
33. Quaiyum MA, Holston M, Hossain SAS, Bell S, Prata N. Scaling Up of Misoprostol for Prevention of Postpartum Hemorrhage in 29 Upazilas of Bangladesh: Final Report 2011, Dhaka, Bangladesh: Venture Strategies Innovations.
34. Engender Health/RESPOND Project Preventing postpartum hemorrhage: Community-based distribution of misoprostol in Tangail District, Bangladesh 2010, New York, Engender Health/RESPOND Project.
35. Walraven G, Blum J, Dampha Y, Sowe M, Morison L, Winikoff B, Sloan N. Misoprostol in the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG 2005, 112:1277-1283. 10.1111/j.1471-0528.2005.00711.x, 16101608.
36. Ghana Health Services, Venture Strategies Innovations Distribution of Misoprostol at Antenatal Care Visits for Prevention of Postpartum Hemorrhage in Ghana: Final Report 2012, Accra, Ghana: Venture Strategies Innovations, Ghana Health Services, Venture Strategies Innovations.
37. Sanghvi H, Wiknjosastro G, Chanpong G, Fishel J, Ahmed S, Zulkarnain M. Prevention of Postpartum Hemorrhage Study 2004, West Java, Indonesia: Jhpiego.
38. Ministry of Public Health and Sanitation, Venture Strategies Innovations, Kenya Obstetrical & Gynaecological Society Introduction of Misoprostol for Prevention of Postpartum Hemorrhage at the Community Level in Kenya: Final Report 2011, Nairobi, Kenya: Venture Strategies Innovations, Ministry of Public Health and Sanitation, Venture Strategies Innovations, Kenya Obstetrical & Gynaecological Society.
39. Associação Moçambicana de Obstetras e Ginecologistas, Venture Strategies Innovations, Bixby Center for Population, Health and Sustainability, PSI/Mozambique Community-based Prevention of Postpartum Hemorrhage with Misoprostol in Mozambique: Final Report 2011, Maputo, Mozambique: Venture Strategies Innovations, Associação Moçambicana de Obstetras e Ginecologistas, Venture Strategies Innovations, Bixby Center for Population, Health and Sustainability, PSI/Mozambique.
40. Ejembi CL, Prata N. Prevention of Postpartum Hemorrhage at Home Births in Five Communities around Zaria, Kaduna State, Nigeria: Technical Report 2010, Venture Strategies Innovations.
41. Mir AM, Wajid A, Gull S. Helping rural women in Pakistan to prevent postpartum hemorrhage: A quasi experimental study. BMC Pregnancy Childbirth 2012, 12:120. 10.1186/1471-2393-12-120, 3514273, 23110458.
42. Ifakara Health Institute, Venture Strategies Innovations, Bixby Center for Population, Health and Sustainability, PSI/Tanzania Prevention of Postpartum Hemorrhage at Home Births: Misoprostol Distribution during Antenatal Care Visits in Tanzania: Final Report 2011, Dar es Salaam, Tanzania: Venture Strategies Innovations, Ifakara Health Institute, Venture Strategies Innovations, Bixby Center for Population, Health and Sustainability, PSI/Tanzania.
43. Ministry of Health, Zambia, Venture Strategies Innovations, Bixby Center for Population, Health and Sustainability Misoprostol Distribution at Antenatal Care Visits for Prevention of Postpartum Hemorrhage: Final Report 2010, Venture Strategies Innovations, Ministry of Health, Zambia, Venture Strategies Innovations, Bixby Center for Population, Health and Sustainability.
44. Population Services International, Society for Family Health Improving maternal health: Preventing post-partum hemorrhage in rural Zambia 2011, Washington, DC: Population Services International, Population Services International, Society for Family Health.
45. PATH Clean delivery kits: Guidelines for their use in programmatic settings http://www.path.org/publications/files/RH_dk_fs.pdf, PATH.
46. WHO Unedited report of the 18th expert committee on the selection and use of essential medicines 2011, http://www.who.int/selection_medicines/Complete_UNEDITED _TRS_18th.pdf, WHO.